Glass House Brands (GLAS) Share-based Compensation Growth (1y) (2021 - 2026)
Glass House Brands (GLAS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 61.54% |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 114.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.87% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | 38.41% |
| Jun 30, 2025 | -18.70% |
| Mar 31, 2025 | -35.67% |
| Dec 31, 2024 | 70.66% |
| Sep 30, 2024 | 14.88% |
| Jun 30, 2024 | 136.36% |
| Mar 31, 2024 | 100.60% |
| Dec 31, 2023 | -49.36% |
| Sep 30, 2023 | -8.76% |
| Jun 30, 2023 | -56.12% |
| Mar 31, 2023 | -39.18% |
| Dec 31, 2022 | 192.13% |
| Sep 30, 2022 | -8.74% |
| Jun 30, 2022 | 323.63% |
| Mar 31, 2022 | 66.95% |
| Dec 31, 2021 | -779.87% |
| Sep 30, 2021 | 390.55% |